ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

Journal of Parkinson's Disease - Netherlands
doi 10.3233/jpd-171134
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Author Correction To: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2018English

Effect of Repeated Intravenous Amantadine Infusions in Patients With Parkinson's Disease: An Open‐Label Pilot Study

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Levodopa-Induced Dyskinesia in Parkinson's Disease: Sleep Matters

Annals of Neurology
Neurology
2018English

An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders

Journal of Ayurveda Medical Sciences
2018English

Controlled-Release Levodopa Methyl Ester/Benserazide-Loaded Nanoparticles Ameliorate Levodopa-Induced Dyskinesia in Rats

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2012English

Dyskinesia in Parkinson’s Disease: A Clinical Complication and an Open Scientific Question

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2018English

158 Open-Label Study of Pimavanserin Patients With Comorbid Parkinson’s Disease and Depression

CNS Spectrums
PsychiatryMental HealthNeurology
2020English

Sensory Tricks for Cervical Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Movement Disorders Clinical Practice
Neurology
2016English

Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy